Ceribell president and CEO Chao Xingjuan sells $145,753 in stock

Ceribell's President and CEO, Chao Xingjuan, recently sold 6,068 shares of the company's common stock on August 21, 2026, according to a regulatory filing. The transaction, which amounted to $145,753, was made to satisfy tax withholding obligations related to the vesting of restricted stock units. Following the sale, Ms. Xingjuan still holds 781,731 shares of Ceribell common stock, in addition to her role as a co-trustee of the ACP 2021 Trust, which owns 369,088 shares.

The insider sale occurred as Ceribell's shares were trading near their 52-week high of $25.33, showing a strong 109% return over the past year. Despite the sale, Ceribell remains a prominent player in the medical device market, boasting impressive gross profit margins of 88.9% and a strong balance sheet with more cash than debt.